This observation together with the 14-3-3/tau dissociation in the CSF (a pattern characterized by presence of 14-3-3 protein and normal tau levels) challenge the hypothesis that 14-3-3 is a marker of neuronal/axonal loss in MS. This evidence concerns the gene MAPT and myeloid sarcoma.